{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:00:06Z","timestamp":1792677606916,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20144-0","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:32:17Z","timestamp":1760711537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["pH-triggered liposomal strategy for cisplatin in lung cancer therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Gulen Melike","family":"Demirbolat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egemen","family":"Cakirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkim Beste","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Sarigul-Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcin Irem","family":"Abas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"20144_CR1","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.21037\/jtd.2017.08.35","volume":"9","author":"C Ou","year":"2017","unstructured":"Ou, C. et al. WWC3: The bridge linking Hippo and Wnt pathways in lung cancer. J. Thorac Dis. 9, 2315\u20132316. https:\/\/doi.org\/10.21037\/jtd.2017.08.35 (2017).","journal-title":"J. Thorac Dis."},{"key":"20144_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.2031","volume":"7","author":"OM Adeyemo","year":"2024","unstructured":"Adeyemo, O. M. et al. Network-based identification of key proteins and repositioning of drugs for non-small cell lung cancer. Cancer Rep. (Hoboken) 7, e2031. https:\/\/doi.org\/10.1002\/cnr2.2031 (2024).","journal-title":"Cancer Rep. (Hoboken)"},{"key":"20144_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4419-0772-1_1","volume-title":"Lung Cancer Metastasis","author":"SM Gadgeel","year":"2009","unstructured":"Gadgeel, S. M. & Kalemkerian, G. P. Lung cancer: Overview. In Lung Cancer Metastasis (eds Keshamouni, V. et al.) 1\u201327 (Springer, 2009). https:\/\/doi.org\/10.1007\/978-1-4419-0772-1_1."},{"key":"20144_CR4","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"A-M Florea","year":"2011","unstructured":"Florea, A.-M. & B\u00fcsselberg, D. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects. Cancers 3, 1351\u20131371. https:\/\/doi.org\/10.3390\/cancers3011351 (2011).","journal-title":"Cancers"},{"key":"20144_CR5","unstructured":"Mishra, V., Sriram, P. & Suttee A. Potential approaches of nanotechnology for cancer therapy: An insight. Int. J. Drug Deliv. Technol. 11 (2021)."},{"key":"20144_CR6","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S34652","author":"M Oliveira","year":"2012","unstructured":"Oliveira, M. et al. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity. IJN https:\/\/doi.org\/10.2147\/IJN.S34652 (2012).","journal-title":"IJN"},{"key":"20144_CR7","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1021\/bc300266y","volume":"23","author":"H-K Kim","year":"2012","unstructured":"Kim, H.-K. et al. Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjugate Chem. 23, 2071\u20132077. https:\/\/doi.org\/10.1021\/bc300266y (2012).","journal-title":"Bioconjugate Chem."},{"key":"20144_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1475-2867-13-89","volume":"13","author":"Y Kato","year":"2013","unstructured":"Kato, Y. et al. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13, 89. https:\/\/doi.org\/10.1186\/1475-2867-13-89 (2013).","journal-title":"Cancer Cell Int."},{"key":"20144_CR9","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/0360-3016(85)90217-2","volume":"11","author":"AJ Thistlethwaite","year":"1985","unstructured":"Thistlethwaite, A. J. et al. pH distribution in human tumors. Int. J. Radiat. Oncol. Biol. Phys. 11, 1647\u20131652. https:\/\/doi.org\/10.1016\/0360-3016(85)90217-2 (1985).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"20144_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2020.110804","volume":"188","author":"S Rayamajhi","year":"2020","unstructured":"Rayamajhi, S. et al. pH-responsive cationic liposome for endosomal escape mediated drug delivery. Colloids Surf. B 188, 110804. https:\/\/doi.org\/10.1016\/j.colsurfb.2020.110804 (2020).","journal-title":"Colloids Surf. B"},{"key":"20144_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120574","volume":"300","author":"B Sheikholeslami","year":"2022","unstructured":"Sheikholeslami, B. et al. Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate. Life Sci. 300, 120574. https:\/\/doi.org\/10.1016\/j.lfs.2022.120574 (2022).","journal-title":"Life Sci."},{"key":"20144_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jpba.2008.01.047","volume":"47","author":"ME Bosch","year":"2008","unstructured":"Bosch, M. E. et al. Analytical methodologies for the determination of cisplatin. J. Pharm. Biomed. Anal. 47, 451\u2013459. https:\/\/doi.org\/10.1016\/j.jpba.2008.01.047 (2008).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"20144_CR13","unstructured":"Sarigul-Ozbek, S., Sa\u011flam, A. B. & Demirbolat, G. M. Validation and development of an HPLC method for cisplatin analysis in solution. J. Turk. Chem. Soc. Sect. A Chem. (2025) (in review)."},{"key":"20144_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102174","volume":"61","author":"A Gouda","year":"2021","unstructured":"Gouda, A. et al. Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications. J. Drug Deliv. Sci. Technol. 61, 102174. https:\/\/doi.org\/10.1016\/j.jddst.2020.102174 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"20144_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejps.2017.03.003","volume":"103","author":"HM Kieler-Ferguson","year":"2017","unstructured":"Kieler-Ferguson, H. M. et al. Encapsulation, controlled release, and antitumor efficacy of cisplatin delivered in liposomes composed of sterol-modified phospholipids. Eur. J. Pharm. Sci. 103, 85\u201393. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.003 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"20144_CR16","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s12247-021-09539-4","volume":"17","author":"GM Demirbolat","year":"2022","unstructured":"Demirbolat, G. M. et al. New approach to formulate methotrexate-loaded niosomes: In vitro characterization and cellular effectiveness. J. Pharm. Innov. 17, 622\u2013637. https:\/\/doi.org\/10.1007\/s12247-021-09539-4 (2022).","journal-title":"J. Pharm. Innov."},{"key":"20144_CR17","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1098\/rsta.2010.0175","volume":"368","author":"M Kaszuba","year":"2010","unstructured":"Kaszuba, M. et al. High-concentration zeta potential measurements using light-scattering techniques. Philos. Trans. R. Soc. A 368, 4439\u20134451. https:\/\/doi.org\/10.1098\/rsta.2010.0175 (2010).","journal-title":"Philos. Trans. R. Soc. A"},{"key":"20144_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.partic.2010.01.003","volume":"8","author":"R Tantra","year":"2010","unstructured":"Tantra, R., Schulze, P. & Quincey, P. Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology 8, 279\u2013285. https:\/\/doi.org\/10.1016\/j.partic.2010.01.003 (2010).","journal-title":"Particuology"},{"key":"20144_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.55730\/1300-0144.5651","volume":"53","author":"AD Ergin","year":"2023","unstructured":"Ergin, A. D. et al. In vitro hepatotoxicity evaluation of methotrexate-loaded niosome formulation: fabrication, characterization and cell culture studies. Turkish J. Med. Sci. 53, 872\u2013882. https:\/\/doi.org\/10.55730\/1300-0144.5651 (2023).","journal-title":"Turkish J. Med. Sci."},{"key":"20144_CR20","unstructured":"Anton Paar GmbH. Litesizer 500 Instruction Manual: Light-Scattering Instrument for Particle Analysis. (Anton Paar GmbH, 2016)."},{"key":"20144_CR21","unstructured":"Mantha, P. Talos L120C TEM for Life Sciences (2019)."},{"key":"20144_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.1365-2818.1998.00282.x","volume":"189","author":"Stokroos","year":"1998","unstructured":"Stokroos, et al. A comparative study of thin coatings of Au\/Pd, Pt and Cr produced by magnetron sputtering for FE-SEM. J. Microscopy 189, 79\u201389. https:\/\/doi.org\/10.1046\/j.1365-2818.1998.00282.x (1998).","journal-title":"J. Microscopy"},{"key":"20144_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102756","volume":"65","author":"P Pakdaman Goli","year":"2021","unstructured":"Pakdaman Goli, P. et al. Preparation and evaluation of gemcitabin and cisplatin-entrapped Folate-PEGylated liposomes as targeting co-drug delivery system in cancer therapy. J. Drug Deliv. Sci. Technol. 65, 102756. https:\/\/doi.org\/10.1016\/j.jddst.2021.102756 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"20144_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.colsurfb.2015.04.029","volume":"131","author":"H Liu","year":"2015","unstructured":"Liu, H. et al. Characterization and cytotoxicity studies of DPPC:M2+ novel delivery system for cisplatin thermosensitivity liposome with improving loading efficiency. Colloids Surf. B 131, 12\u201320. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.04.029 (2015).","journal-title":"Colloids Surf. B"},{"key":"20144_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/ijms21020559","volume":"21","author":"M Ghaferi","year":"2020","unstructured":"Ghaferi, M. et al. Enhanced efficacy of PEGylated liposomal cisplatin: In vitro and in vivo evaluation. Int. J. Mol. Sci. 21, 559. https:\/\/doi.org\/10.3390\/ijms21020559 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"20144_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12, 263\u2013271. https:\/\/doi.org\/10.1208\/s12248-010-9185-1 (2010).","journal-title":"AAPS J."},{"key":"20144_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.29238\/teknolabjournal.v11i2.313","volume":"11","author":"BN Ikasari","year":"2022","unstructured":"Ikasari, B. N. et al. Effect of fetal bovine serum concentration towards vero cells growth on culture in DMEM medium. J. Teknol. Laboratorium 11, 73\u201377. https:\/\/doi.org\/10.29238\/teknolabjournal.v11i2.313 (2022).","journal-title":"J. Teknol. Laboratorium"},{"key":"20144_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0166-0934(91)90047-4","volume":"32","author":"JJ Gray","year":"1991","unstructured":"Gray, J. J. & Brenwald, N. P. The use of antibiotics to control bacterial overgrowth of cell cultures used for diagnostic virology. J. Virol. Methods 32, 163\u2013170. https:\/\/doi.org\/10.1016\/0166-0934(91)90047-4 (1991).","journal-title":"J. Virol. Methods"},{"key":"20144_CR29","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot095505","author":"P Kumar","year":"2018","unstructured":"Kumar, P., Nagarajan, A. & Uchil, P. D. Analysis of cell viability by the MTT assay. Cold Spring Harb. Protoc. https:\/\/doi.org\/10.1101\/pdb.prot095505 (2018).","journal-title":"Cold Spring Harb. Protoc."},{"key":"20144_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2144\/btn-2022-0064","volume":"73","author":"J Nilles","year":"2022","unstructured":"Nilles, J., Weiss, J. & Theile, D. Crystal violet staining is a reliable alternative to bicinchoninic acid assay-based normalization. Biotechniques 73, 131\u2013135. https:\/\/doi.org\/10.2144\/btn-2022-0064 (2022).","journal-title":"Biotechniques"},{"key":"20144_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110378","volume":"129","author":"R Zhang","year":"2020","unstructured":"Zhang, R. et al. PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K\/Akt\/mTOR signaling pathway in A549 cells. Biomed. Pharmacother. 129, 110378. https:\/\/doi.org\/10.1016\/j.biopha.2020.110378 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"20144_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11339-1","author":"LF Eggers","year":"2017","unstructured":"Eggers, L. F. et al. Lipidomes of lung cancer and tumour-free lung tissues reveal distinct molecular signatures for cancer differentiation, age, inflammation, and pulmonary emphysema. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-017-11339-1 (2017).","journal-title":"Sci. Rep."},{"key":"20144_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106779","volume":"197","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Preparation and evaluation of inhalable S-allylmercapto-N-acetylcysteine and nintedanib co-loaded liposomes for pulmonary fibrosis. Eur. J. Pharm. Sci. 197, 106779. https:\/\/doi.org\/10.1016\/j.ejps.2024.106779 (2024).","journal-title":"Eur. J. Pharm. Sci."},{"key":"20144_CR34","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-021-01973-4","author":"X Hu","year":"2021","unstructured":"Hu, X. et al. Galactose-modified PH-sensitive niosomes for controlled release and hepatocellular carcinoma target delivery of Tanshinone IIA. AAPS PharmSciTech https:\/\/doi.org\/10.1208\/s12249-021-01973-4 (2021).","journal-title":"AAPS PharmSciTech"},{"key":"20144_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28171","volume":"10","author":"R Ranasinghe","year":"2024","unstructured":"Ranasinghe, R. et al. Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm. Heliyon 10, e28171. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28171 (2024).","journal-title":"Heliyon"},{"key":"20144_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102400","volume":"62","author":"MS Franco","year":"2021","unstructured":"Franco, M. S. et al. Investigation of the antitumor activity and toxicity of cisplatin loaded pH-sensitive-pegylated liposomes in a triple negative breast cancer animal model. J. Drug Deliv. Sci. Technol. 62, 102400. https:\/\/doi.org\/10.1016\/j.jddst.2021.102400 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"20144_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics14010129","volume":"14","author":"H Shah","year":"2022","unstructured":"Shah, H. et al. pH-responsive liposomes of dioleoyl phosphatidylethanolamine and cholesteryl hemisuccinate for the enhanced anticancer efficacy of cisplatin. Pharmaceutics 14, 129. https:\/\/doi.org\/10.3390\/pharmaceutics14010129 (2022).","journal-title":"Pharmaceutics"},{"key":"20144_CR38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/jpp\/rgab156","volume":"74","author":"RS Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo, R. S. et al. The effect of free and encapsulated cisplatin into long-circulating and pH-sensitive liposomes on IEC-6 cells during wound healing in the presence of host\u2013microbiota. J. Pharm. Pharmacol. 74, 711\u2013717. https:\/\/doi.org\/10.1093\/jpp\/rgab156 (2022).","journal-title":"J. Pharm. Pharmacol."},{"key":"20144_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphy.2021.636149","author":"A Ba\u00f1uelos-Frias","year":"2021","unstructured":"Ba\u00f1uelos-Frias, A. et al. Thermodynamic and mechanical properties of DMPC\/cholesterol mixed monolayers at physiological conditions. Front Phys. https:\/\/doi.org\/10.3389\/fphy.2021.636149 (2021).","journal-title":"Front Phys."},{"key":"20144_CR40","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3390\/pharmaceutics14061128","volume":"14","author":"H Alrbyawi","year":"2022","unstructured":"Alrbyawi, H. et al. pH-sensitive liposomes for enhanced cellular uptake and cytotoxicity of Daunorubicin in melanoma (B16-BL6) cell lines. Pharmaceutics 14, 1128. https:\/\/doi.org\/10.3390\/pharmaceutics14061128 (2022).","journal-title":"Pharmaceutics"},{"key":"20144_CR41","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.xphs.2018.01.006","volume":"107","author":"GM Demirbolat","year":"2018","unstructured":"Demirbolat, G. M. et al. Development of orally applicable, combinatorial drug-loaded nanoparticles for the treatment of fibrosarcoma. J. Pharm. Sci. 107, 1398\u20131407. https:\/\/doi.org\/10.1016\/j.xphs.2018.01.006 (2018).","journal-title":"J. Pharm. Sci."},{"key":"20144_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105576","volume":"156","author":"M Karpuz","year":"2021","unstructured":"Karpuz, M. et al. Diagnostic and therapeutic evaluation of folate-targeted paclitaxel and vinorelbine encapsulating theranostic liposomes for non-small cell lung cancer. Eur. J. Pharm. Sci. 156, 105576. https:\/\/doi.org\/10.1016\/j.ejps.2020.105576 (2021).","journal-title":"Eur. J. Pharm. Sci."},{"key":"20144_CR43","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/pharmaceutics16121525","volume":"16","author":"IL Dejeu","year":"2024","unstructured":"Dejeu, I. L. et al. Innovative approaches to enhancing the biomedical properties of liposomes. Pharmaceutics 16, 1525. https:\/\/doi.org\/10.3390\/pharmaceutics16121525 (2024).","journal-title":"Pharmaceutics"},{"key":"20144_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","volume":"14","author":"D Lombardo","year":"2022","unstructured":"Lombardo, D. & Kiselev, M. A. Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application. Pharmaceutics 14, 543. https:\/\/doi.org\/10.3390\/pharmaceutics14030543 (2022).","journal-title":"Pharmaceutics"},{"key":"20144_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12668-022-00941-x","volume":"12","author":"VVSNL Andra","year":"2022","unstructured":"Andra, V. V. S. N. L. et al. A comprehensive review on novel liposomal methodologies, commercial formulations, clinical trials and patents. BioNanoSci 12, 274\u2013291. https:\/\/doi.org\/10.1007\/s12668-022-00941-x (2022).","journal-title":"BioNanoSci"},{"key":"20144_CR46","doi-asserted-by":"publisher","first-page":"D196","DOI":"10.1149\/2.0501805jes","volume":"165","author":"Y-L Lai","year":"2018","unstructured":"Lai, Y.-L. et al. Electrochemical deposition of cisplatin on pure magnesium. J. Electrochem. Soc. 165, D196-205. https:\/\/doi.org\/10.1149\/2.0501805jes (2018).","journal-title":"J. Electrochem. Soc."},{"key":"20144_CR47","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12221-017-6958-5","volume":"18","author":"FF Azhar","year":"2017","unstructured":"Azhar, F. F., Shahbazpour, E. & Olad, A. pH sensitive and controlled release system based on cellulose nanofibers-poly vinyl alcohol hydrogels for cisplatin delivery. Fibers Polym. 18, 416\u2013423. https:\/\/doi.org\/10.1007\/s12221-017-6958-5 (2017).","journal-title":"Fibers Polym."},{"key":"20144_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0378-5173(96)04815-6","volume":"147","author":"Y Yokomizo","year":"1997","unstructured":"Yokomizo, Y. Effect of phosphatidylglycerol on the in vitro percutaneous drug penetration through the dorsal skin of guinea pigs, and analysis of the molecular mechanism, using (ATR-FTIR) spectroscopy. Int. J. Pharm. 147, 219\u2013231. https:\/\/doi.org\/10.1016\/s0378-5173(96)04815-6 (1997).","journal-title":"Int. J. Pharm."},{"key":"20144_CR49","doi-asserted-by":"publisher","first-page":"125688","DOI":"10.1016\/j.molliq.2024.125688","volume":"411","author":"DS Tretiakova","year":"2024","unstructured":"Tretiakova, D. S. et al. Phosphatidylglycerol in lipid bilayer. Molecular recognition, conformational transitions, hydrogen bonding and microviscosity. J. Mol. Liq. 411, 125688. https:\/\/doi.org\/10.1016\/j.molliq.2024.125688 (2024).","journal-title":"J. Mol. Liq."},{"key":"20144_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01353-5","author":"B Deng","year":"2022","unstructured":"Deng, B. et al. Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment. J. Nanobiotechnol. https:\/\/doi.org\/10.1186\/s12951-022-01353-5 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"20144_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1155\/2008\/690574","volume":"22","author":"A Aamouche","year":"2008","unstructured":"Aamouche, A. & Goormaghtigh, E. FTIR-ATR biosensor based on self-assembled phospholipids surface: Haemophilia factor VIII diagnosis. Spectroscopy 22, 223\u2013234. https:\/\/doi.org\/10.1155\/2008\/690574 (2008).","journal-title":"Spectroscopy"},{"key":"20144_CR52","unstructured":"Usta, D. Y., Demi\u0307Rta\u015f, \u00d6. & \u00d6k\u00e7eli\u0307K, C, et al. Evaluation of in vitro dissolution characteristics of flurbiprofen, a BCS class IIa drug. Fabad J. Pharmaceut. Sci. 43(2), 27\u201334 (2018)."},{"key":"20144_CR53","unstructured":"Dash, S. et al. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol. Pharm. 67 (3), 217\u2013223. https:\/\/pubmed.ncbi.nlm.nih.gov\/20524422\/ (2010)."},{"key":"20144_CR54","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02922-7","author":"P Porbaha","year":"2024","unstructured":"Porbaha, P. et al. A comparative mathematical analysis of drug release from lipid-based nanoparticles. AAPS PharmSciTech https:\/\/doi.org\/10.1208\/s12249-024-02922-7 (2024).","journal-title":"AAPS PharmSciTech"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20144-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20144-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:32:18Z","timestamp":1760711538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20144-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20144"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20144-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36349"}}